VCYT - Latest News
Veracyte, Inc. (VCYT), operates in Healthcare / Medical - Diagnostics & Research, trades on NASDAQ.
Market capitalization stands near $3.44B. Trailing twelve-month P/E ratio is 30.00. Beta to the broader market is 1.95.
The article list below shows the most recent VCYT headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent VCYT Headlines
Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026
globenewswire.com - Oct 14, 2026
SOUTH SAN FRANCISCO, Calif. , Oct.
Phase III Trial Demonstrates Veracyte's Decipher Prostate Test Predicts Benefit from Adding Hormone Therapy to Radiation
globenewswire.com - Sep 29, 2026
SOUTH SAN FRANCISCO, Calif. , Sept.
Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026
globenewswire.com - Sep 25, 2026
Six oral presentations and two posters will highlight Decipher's prognostic and predictive value in identifying patients' risk of progression and like
Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?
zacks.com - Sep 25, 2026
Veracyte (VCYT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the
Veracyte (NASDAQ:VCYT) Insider John Leite Sells 4,015 Shares
defenseworld.net - Sep 23, 2026
Veracyte, Inc. (NASDAQ: VCYT - Get Free Report) insider John Leite sold 4,015 shares of Veracyte stock in a transaction dated Monday, September 21st.
How News Affects VCYT Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track VCYT's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked VCYT news questions
- What is the latest VCYT news headline?
- The most recent VCYT headline (Oct 14, 2026) is "Veracyte to Release Third Quarter 2026 Financial Results on November 4, 2026". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the VCYT news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What VCYT news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual VCYT options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.